U.S., April 29 -- ClinicalTrials.gov registry received information related to the study (NCT07554690) titled 'Photobiomodulation Laser for Reticular Pseudodrusen in Age-Related Macular Degeneration' on April 21.
Brief Summary: This study evaluates whether a low-energy laser treatment called photobiomodulation (PBM) can improve visual function and retinal structure in patients with age-related macular degeneration (AMD) who have reticular pseudodrusen. PBM is a non-invasive therapy that uses specific wavelengths of light to stimulate cellular activity and reduce inflammation without causing tissue damage.
Participants will be randomly assigned to receive either active PBM treatment or a sham (inactive) treatment. The study will assess chan...